Caribou Biosciences

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$2,198
$2,667
$2,353
$2,077
Gross Profit
1,567
2,667
2,353
-27,787
EBITDA
-26,917
-34,261
-41,748
-37,091
EBIT
-27,548
-35,428
-42,913
-38,275
Net Income
-27,548
-54,098
-39,991
-35,490
Net Change In Cash
2,198
2,667
2,353
2,077
Free Cash Flow
-25,300
-28,676
-37,767
-35,988
Cash
11,144
25,201
29,417
16,293
Basic Shares
93,293
93,028
92,679
90,317

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$9,994
$34,477
$13,851
$9,598
Gross Profit
6,067
30,952
10,210
8,614
EBITDA
-162,689
-112,534
-104,777
-65,610
EBIT
-166,616
-116,059
-106,399
-66,594
Net Income
-149,105
-102,070
-99,421
-66,923
Net Change In Cash
9,994
34,477
13,851
9,598
Cost of Revenue
-182,082
224,513
Free Cash Flow
-144,705
-104,904
-97,420
-35,640
Cash
16,293
51,162
58,338
240,420
Basic Shares
90,317
73,807
60,801
60,263

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.30
2025-06-30
-$0.58
2025-03-31
-$0.43